During the past decade, Connecticut Clinical Research conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 10 clinical trials were completed, i.e. on average, 62.5% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 7 clinical trials were completed. i.e. 70% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Connecticut Clinical Research" #1 sponsor was "Janssen Research & Development, LLC" with 3 trials, followed by "Otsuka Pharmaceutical Development & Commercialization, Inc." with 3 trials sponsored, "Pfizer" with 3 trials sponsored, "Biohaven Pharmaceuticals, Inc." with 2 trials sponsored and "Bristol-Myers Squibb" with 2 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 13 trials in total.

According to Clinical.Site data, the most researched conditions in "Connecticut Clinical Research" are "Depressive Disorder, Major" (3 trials), "Major Depressive Disorder" (3 trials), "Agitation in Patients With Dementia of the Alzheimer's Type" (2 trials), "Binge Eating Disorder" (2 trials) and "Depression" (2 trials). Many other conditions were trialed in "Connecticut Clinical Research" in a lesser frequency.

Most popular intervention types in "Connecticut Clinical Research" are "Drug" (23 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "AVP-786" (3 trials), "Aticaprant" (2 trials), "BMS-820836" (2 trials) and "Duloxetine" (2 trials). Other intervention names were less common.

The vast majority of trials in "Connecticut Clinical Research" are 22 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Connecticut Clinical Research". undefined are not yet recruiting, 6 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in Connecticut Clinical Research, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Connecticut Clinical Research, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".